Smoking heart disease
Results from a new study in patients with type 2 diabetes demonstrate that daily supplementation with 1000 mcg of chromium as chromium picolinate, in combination with a common oral anti-diabetic medication, improves insulin sensitivity and glucose control better than the oral anti-diabetic agent alone. [click link for full article]
European Approval For Galvus Sought, An Innovative Oral Treatment For People With Type 2 Diabetes
Novartis announced that it has submitted Galvus * (vildagliptin) for European approval for the treatment of type 2 diabetes. Galvus is a new, once-daily oral therapy that has demonstrated impressive blood sugar lowering effects, even among difficult-to-treat patients who have poor glycemic control, are obese or older than 65[1]. [click link for full article]
Relapse is just part of managing chronic alcoholism
Mel Gibson’s relapse was a public humiliation. Robin Williams, who “found himself drinking again” after 20 years of sobriety, according to a statement released last week, had a private one. Both are back in treatment as some of their legion of followers “tsk-tsk,” shake their heads and conclude that two more stars have failed.
InforMedix Signs University of Pennsylvania as First Self-Insured Employer Customer
ROCKVILLE, Md.—-Aug. 16, 2006–InforMedix Holdings, Inc. today announced plans to offer the Med-eMonitor System, developed and patented by InforMedix, to selected University of Pennsylvania employees and retirees with chronic health care conditions known to cause high rates of stroke, heart disease, premature death, and reduced quality-of-life.
Tags: Heart Disease
